# IlDong Pharmaceutical Co Ltd

Organization · id `cardio:org-ildong-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=IlDong+Pharmaceutical+Co+Ltd>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: IlDong Pharmaceutical Co Ltd
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia (`cardio:ct-nct02087540`)
- Sponsors: Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension (`cardio:ct-nct02145104`)
- Sponsors: The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (`cardio:ct-nct02251847`)
- Sponsors: Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients (`cardio:ct-nct02738632`)
- Sponsors: A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study) (`cardio:ct-nct02749994`)
- Sponsors: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) (`cardio:ct-nct05845489`)

## Provenance

Content hash: bffe6438f3fc144bd4c5972f571351138a88ad152b893b0a7cb627423d114a36
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
